Depression Clinical Trials in New Haven, Connecticut

5 studies are recruiting for depression in New Haven, Connecticut right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. PCORI Comparative Effectiveness Study-Esketamine (Spravato) vs. Ketamine-Equivalence Study

   The purpose of this study is to compare the relative effectiveness, acceptability, and side effects of ketamine delivered through an IV (a drip into the arm) which is not currently FDA approved for use in the treatment of treatment-resistant depression (TRD) and Esketamine (Spravato®), taken as a n…

   Stage

   Phase 3

   Ages

   18 and older

   Site

   Yale School of Medicine, New Haven, Connecticut

   Locations

   8 in total

   Run by

   Yale University

   See if you can join NCT06713616 on ClinicalTrials.gov

2. A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

   The purpose of this study is to determine the efficacy, safety and tolerability of CYB003 compared to matching placebo as adjunctive treatment in patients with MDD. For more information about the EMBRACE study, including participating study locations, and to register your interest in learning more …

   Stage

   Phase 3

   Ages

   18 to 85

   Site

   Yale School of Medicine - Yale Program for Psychedelic Science, New Haven, Connecticut

   Locations

   69 in total

   Run by

   Cybin IRL Limited

   See if you can join NCT06793397 on ClinicalTrials.gov

3. The Efficacy of Psilocybin Therapy for Depression in Parkinson's Disease

   The purpose of this study is to understand whether people with Parkinson's Disease and depression have improvement in their symptoms after psilocybin therapy.

   Stage

   Phase 2

   Ages

   40 to 80

   Site

   Yale University, New Haven, Connecticut

   Run by

   Yale University

   See if you can join NCT07610369 on ClinicalTrials.gov

4. Assessing the Effectiveness of Digital Wellness Modules on Perceived Quality of Life

   The study will examine the role of digital wellness modules (brief mindfulness and light to moderate physical exercise) delivered through a smartphone wellness application and their short-term effects on health behavior motivation and change, and longer-term quality of life and non-pathological aff…

   Stage

   Not phased

   Ages

   18 to 65

   Site

   Yale University, New Haven, Connecticut

   Run by

   Yale University

   See if you can join NCT05810259 on ClinicalTrials.gov

5. Stress and Pain in People Living With HIV

   This is a basic human experimental study utilizing 4 groups of individuals with and without HIV and complex morbidities of cannabis use disorder and major depression who will participate in 2 sessions of the Yale Pain Stress Task (YPST) and follow-up phase to assess drug use and mood symptoms.

   Stage

   Not phased

   Ages

   18 to 68

   Site

   The Yale Stress Center, New Haven, Connecticut

   Run by

   Yale University

   See if you can join NCT06784908 on ClinicalTrials.gov